ZNF558
gene geneOn this page
Also known as FLJ30932
Summary
ZNF558 (zinc finger protein 558, HGNC:26422) is a protein-coding gene on chromosome 19p13.2, encoding Zinc finger protein 558 (Q96NG5). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 148156 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 45 total
- MANE Select transcript:
NM_144693
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26422 |
| Approved symbol | ZNF558 |
| Name | zinc finger protein 558 |
| Location | 19p13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ30932 |
| Ensembl gene | ENSG00000167785 |
| Ensembl biotype | protein_coding |
| Entrez | 148156 |
Gene structure
Transcript identifiers
Ensembl transcripts: 24 — 19 protein_coding, 3 protein_coding_CDS_not_defined, 2 retained_intron
ENST00000301475, ENST00000593891, ENST00000595786, ENST00000596172, ENST00000597304, ENST00000599938, ENST00000601372, ENST00000869419, ENST00000869420, ENST00000869421, ENST00000869422, ENST00000869423, ENST00000971724, ENST00000971725, ENST00000971726, ENST00000971727, ENST00000971728, ENST00000971729, ENST00000971730, ENST00000971731, ENST00000971732, ENST00000971733, ENST00000971734, ENST00000971735
RefSeq mRNA: 1 — MANE Select: NM_144693
NM_144693
CCDS: CCDS12208
Canonical transcript exons
ENST00000601372 — 10 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001153986 | 8822003 | 8822091 |
| ENSE00003012103 | 8806170 | 8812063 |
| ENSE00003039224 | 8831318 | 8831401 |
| ENSE00003045567 | 8832209 | 8832304 |
| ENSE00003049458 | 8825002 | 8825108 |
| ENSE00003114735 | 8824082 | 8824417 |
| ENSE00003490038 | 8821180 | 8821306 |
| ENSE00003543455 | 8812561 | 8812643 |
| ENSE00003543535 | 8822629 | 8822724 |
| ENSE00003615830 | 8813127 | 8813222 |
Expression profiles
Bgee: expression breadth ubiquitous, 236 present calls, max score 89.62.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 3.5479 / max 49.4953, expressed in 1420 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 178975 | 1.8317 | 1015 |
| 178974 | 1.7161 | 988 |
Top tissues by expression
249 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| body of uterus | UBERON:0009853 | 89.62 | gold quality |
| cortical plate | UBERON:0005343 | 89.19 | gold quality |
| secondary oocyte | CL:0000655 | 89.11 | gold quality |
| left ovary | UBERON:0002119 | 88.91 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 88.88 | gold quality |
| lower esophagus | UBERON:0013473 | 88.87 | gold quality |
| ganglionic eminence | UBERON:0004023 | 88.79 | gold quality |
| right uterine tube | UBERON:0001302 | 88.72 | gold quality |
| tibialis anterior | UBERON:0001385 | 88.70 | silver quality |
| left uterine tube | UBERON:0001303 | 88.26 | gold quality |
| right ovary | UBERON:0002118 | 88.20 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 88.06 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 87.67 | silver quality |
| oocyte | CL:0000023 | 87.52 | gold quality |
| ventricular zone | UBERON:0003053 | 87.52 | gold quality |
| ovary | UBERON:0000992 | 87.36 | gold quality |
| oviduct epithelium | UBERON:0004804 | 87.25 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 87.23 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 86.75 | gold quality |
| fallopian tube | UBERON:0003889 | 86.64 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 86.63 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 86.59 | gold quality |
| endocervix | UBERON:0000458 | 86.55 | gold quality |
| body of pancreas | UBERON:0001150 | 86.30 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 86.11 | gold quality |
| thyroid gland | UBERON:0002046 | 86.08 | gold quality |
| tibia | UBERON:0000979 | 86.07 | gold quality |
| tibial nerve | UBERON:0001323 | 85.96 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 85.87 | gold quality |
| right adrenal gland | UBERON:0001233 | 85.75 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 5.82 |
Regulation
Is transcription factor: yes
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA2335.1 | ZNF558 | More than 3 adjacent zinc fingers |
JASPAR matrix evidence (PMIDs): PMID:28273063
miRNA regulators (miRDB)
69 targeting ZNF558, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6833-3P | 100.00 | 70.63 | 3197 |
| HSA-MIR-4768-5P | 100.00 | 69.49 | 2861 |
| HSA-MIR-4673 | 100.00 | 66.64 | 1490 |
| HSA-MIR-4682 | 100.00 | 68.89 | 1258 |
| HSA-MIR-6873-3P | 100.00 | 71.42 | 2626 |
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-4645-5P | 99.98 | 65.81 | 1284 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-141-3P | 99.94 | 72.79 | 2421 |
| HSA-MIR-200A-3P | 99.94 | 72.68 | 2420 |
| HSA-MIR-381-3P | 99.93 | 71.87 | 2854 |
| HSA-MIR-4778-3P | 99.93 | 70.40 | 1818 |
| HSA-MIR-300 | 99.92 | 71.76 | 2856 |
| HSA-MIR-6809-3P | 99.91 | 71.45 | 3814 |
| HSA-MIR-7-1-3P | 99.91 | 71.53 | 4384 |
| HSA-MIR-7-2-3P | 99.91 | 71.40 | 4394 |
| HSA-MIR-374A-5P | 99.90 | 71.34 | 2923 |
| HSA-MIR-629-3P | 99.85 | 67.99 | 1875 |
| HSA-MIR-4420 | 99.82 | 70.08 | 1624 |
| HSA-MIR-181B-2-3P | 99.81 | 70.06 | 1646 |
| HSA-MIR-181B-3P | 99.81 | 70.06 | 1646 |
| HSA-MIR-3680-3P | 99.75 | 72.51 | 3095 |
| HSA-MIR-8084 | 99.73 | 69.57 | 1760 |
| HSA-MIR-1825 | 99.72 | 68.11 | 1089 |
| HSA-MIR-33A-3P | 99.70 | 70.27 | 3362 |
| HSA-MIR-7161-5P | 99.68 | 68.92 | 1592 |
| HSA-MIR-12124 | 99.68 | 69.17 | 2700 |
| HSA-MIR-545-5P | 99.66 | 70.18 | 2308 |
Literature-anchored findings (GeneRIF, showing 1)
- A cis-acting structural variation at the ZNF558 locus controls a gene regulatory network in human brain development. (PMID:34624206)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Zfp558 | ENSMUSG00000074500 |
| drosophila_melanogaster | CG2712 | FBGN0024975 |
| drosophila_melanogaster | Phs | FBGN0036522 |
| drosophila_melanogaster | CG3281 | FBGN0260741 |
Paralogs (62): ZNF582 (ENSG00000018869), ZNF264 (ENSG00000083844), ZNF343 (ENSG00000088876), ZNF684 (ENSG00000117010), ZNF133 (ENSG00000125846), ZNF557 (ENSG00000130544), ZNF337 (ENSG00000130684), ZNF20 (ENSG00000132010), ZFP37 (ENSG00000136866), ZNF614 (ENSG00000142556), KRBOX4 (ENSG00000147121), ZNF599 (ENSG00000153896), ZNF19 (ENSG00000157429), ZNF589 (ENSG00000164048), PRDM9 (ENSG00000164256), ZNF180 (ENSG00000167384), ZNF35 (ENSG00000169981), ZNF778 (ENSG00000170100), ZNF439 (ENSG00000171291), ZNF440 (ENSG00000171295), ZNF556 (ENSG00000172000), ZNF554 (ENSG00000172006), ZNF596 (ENSG00000172748), ZNF80 (ENSG00000174255), ZNF266 (ENSG00000174652), ZNF25 (ENSG00000175395), ZNF77 (ENSG00000175691), ZNF169 (ENSG00000175787), ZNF404 (ENSG00000176222), ZNF491 (ENSG00000177599), ZNF620 (ENSG00000177842), ZNF619 (ENSG00000177873), ZNF875 (ENSG00000181666), ZNF329 (ENSG00000181894), ZFP90 (ENSG00000184939), ZNF566 (ENSG00000186017), ZNF529 (ENSG00000186020), ZNF749 (ENSG00000186230), ZNF555 (ENSG00000186300), ZNF70 (ENSG00000187792)
Protein
Protein identifiers
Zinc finger protein 558 — Q96NG5 (reviewed: Q96NG5)
All UniProt accessions (1): Q96NG5
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q96NG5-1 | 1 | yes |
| Q96NG5-2 | 2 |
RefSeq proteins (1): NP_653294* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF01352, PF13465, PF13912
UniProt features (12 total): zinc finger region 9, chain 1, domain 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96NG5-F1 | 73.94 | 0.33 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 46 (showing top):
chr19p13, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, CHAF1B_TARGET_GENES, DIDO1_TARGET_GENES, ELF2_TARGET_GENES, KAT5_TARGET_GENES, LHX9_TARGET_GENES, NFKBIA_TARGET_GENES, RBM34_TARGET_GENES, ZBTB12_TARGET_GENES, ZNF146_TARGET_GENES, MIR300, MIR381_3P, MIR33A_3P
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (6): RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| transcription cis-regulatory region binding | 1 |
| chromatin | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
616 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF558 | TRIM61 | Q5EBN2 | 644 |
| ZNF558 | OR2Z1 | Q8NG97 | 635 |
| ZNF558 | SPATA18 | Q8TC71 | 478 |
| ZNF558 | MBD3L1 | Q8WWY6 | 469 |
| ZNF558 | LCE2D | Q5TA82 | 413 |
| ZNF558 | TAF9B | Q9HBM6 | 396 |
| ZNF558 | MAGEA11 | P43364 | 394 |
| ZNF558 | PRAMEF14 | Q5SWL7 | 366 |
| ZNF558 | ZNF608 | Q9ULD9 | 365 |
| ZNF558 | ZZZ3 | Q8IYH5 | 359 |
| ZNF558 | FCGR2A | P12318 | 353 |
| ZNF558 | ACTL9 | Q8TC94 | 352 |
| ZNF558 | FSTL4 | Q6MZW2 | 346 |
| ZNF558 | ZBTB21 | Q9ULJ3 | 342 |
| ZNF558 | C9JR48 | C9JR48 | 327 |
IntAct
36 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| GSDMD | ZNF558 | psi-mi:“MI:0915”(physical association) | 0.560 |
| EFEMP2 | ZNF558 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LZIC | ZNF558 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MFAP1 | ZNF558 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CLK2 | ZNF558 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HEXIM2 | ZNF558 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF558 | MAD2L2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| EIF1AD | ZNF558 | psi-mi:“MI:0915”(physical association) | 0.560 |
| UBTFL1 | ZNF558 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CSNK2A1 | ZNF558 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRIM28 | ZNF320 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF558 | RCBTB2 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF558 | SERPINA1 | psi-mi:“MI:0914”(association) | 0.350 |
| CLK2 | ZNF558 | psi-mi:“MI:0915”(physical association) | 0.000 |
| EFEMP2 | ZNF558 | psi-mi:“MI:0915”(physical association) | 0.000 |
| LZIC | ZNF558 | psi-mi:“MI:0915”(physical association) | 0.000 |
| MFAP1 | ZNF558 | psi-mi:“MI:0915”(physical association) | 0.000 |
| HEXIM2 | ZNF558 | psi-mi:“MI:0915”(physical association) | 0.000 |
| UBTFL1 | ZNF558 | psi-mi:“MI:0915”(physical association) | 0.000 |
| CSNK2A1 | ZNF558 | psi-mi:“MI:0915”(physical association) | 0.000 |
| MAD2L2 | ZNF558 | psi-mi:“MI:0915”(physical association) | 0.000 |
| EIF1AD | ZNF558 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (33): ZNF558 (Affinity Capture-RNA), ZNF558 (Affinity Capture-RNA), ALB (Affinity Capture-MS), APOA1 (Affinity Capture-MS), SERPINA1 (Affinity Capture-MS), RCBTB2 (Affinity Capture-MS), APOA1 (Affinity Capture-MS), SERPINA1 (Affinity Capture-MS), RCBTB2 (Affinity Capture-MS), FTL (Affinity Capture-MS), ALB (Affinity Capture-MS), ZNF558 (Two-hybrid), ZNF558 (Two-hybrid), ZNF558 (Two-hybrid), ZNF558 (Two-hybrid)
ESM2 similar proteins: A0JPL0, A1L1L7, A3KN32, A3KN36, D3ZVT0, O43296, P08042, P16373, P17023, P17031, P52738, P85977, Q02975, Q12901, Q14592, Q29RZ4, Q3KNS6, Q4R6J4, Q4V8A8, Q571J5, Q5CZA5, Q5JNZ3, Q5R7I8, Q5RB33, Q5RBY9, Q5T5D7, Q61751, Q61967, Q62396, Q6GQR8, Q6ZNG0, Q6ZS27, Q7Z398, Q8BI99, Q8BIQ3, Q8IVC4, Q8IZ26, Q8N988, Q8N9Z0, Q8NDP4
Diamond homologs: A0A1W2PQL4, A0JNB1, A0JPL0, A6NK53, A6QLU5, A6QPT6, A7MBI1, A8MT65, A8MUV8, A8MWA4, B2RXC5, B4DU55, B4DX44, E9PYI1, O14628, O75346, P0CH99, P0CI00, P17014, P17030, P17032, P17098, P51786, P85977, Q02386, Q06730, Q06732, Q0VAW7, Q12901, Q13360, Q14586, Q14588, Q14590, Q16587, Q2M3X9, Q2VY69, Q32M78, Q3ZCX4, Q49AA0, Q4R6J4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
45 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 36 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1788 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:8812555:TCTTA:T | donor_loss | 1.0000 |
| 19:8812556:CTTAC:C | donor_loss | 1.0000 |
| 19:8812557:TTACC:T | donor_loss | 1.0000 |
| 19:8812558:TACCG:T | donor_loss | 1.0000 |
| 19:8812559:A:C | donor_loss | 1.0000 |
| 19:8812560:C:CT | donor_loss | 1.0000 |
| 19:8812640:AAATC:A | acceptor_loss | 1.0000 |
| 19:8812642:ATCTG:A | acceptor_loss | 1.0000 |
| 19:8812643:TC:T | acceptor_loss | 1.0000 |
| 19:8812644:C:A | acceptor_loss | 1.0000 |
| 19:8812644:C:CC | acceptor_gain | 1.0000 |
| 19:8812645:T:G | acceptor_loss | 1.0000 |
| 19:8813121:GCTCA:G | donor_loss | 1.0000 |
| 19:8813122:CTCA:C | donor_loss | 1.0000 |
| 19:8813124:CAC:C | donor_loss | 1.0000 |
| 19:8813125:A:AT | donor_loss | 1.0000 |
| 19:8813219:CACC:C | acceptor_gain | 1.0000 |
| 19:8813221:CC:C | acceptor_gain | 1.0000 |
| 19:8813222:CCTA:C | acceptor_gain | 1.0000 |
| 19:8813223:CT:C | acceptor_loss | 1.0000 |
| 19:8813224:T:C | acceptor_loss | 1.0000 |
| 19:8821174:GCTTA:G | donor_loss | 1.0000 |
| 19:8821175:CTTAC:C | donor_loss | 1.0000 |
| 19:8821176:TTACC:T | donor_loss | 1.0000 |
| 19:8821177:TACCT:T | donor_loss | 1.0000 |
| 19:8821178:A:AC | donor_gain | 1.0000 |
| 19:8821178:ACCTA:A | donor_loss | 1.0000 |
| 19:8821179:C:CA | donor_gain | 1.0000 |
| 19:8821179:CCT:C | donor_gain | 1.0000 |
| 19:8821179:CCTA:C | donor_gain | 1.0000 |
AlphaMissense
2679 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:8811503:G:C | F329L | 0.996 |
| 19:8811503:G:T | F329L | 0.996 |
| 19:8811505:A:G | F329L | 0.996 |
| 19:8811587:G:C | F301L | 0.996 |
| 19:8811587:G:T | F301L | 0.996 |
| 19:8811589:A:G | F301L | 0.996 |
| 19:8811839:A:C | F217L | 0.996 |
| 19:8811839:A:T | F217L | 0.996 |
| 19:8811841:A:G | F217L | 0.996 |
| 19:8811335:G:C | F385L | 0.995 |
| 19:8811335:G:T | F385L | 0.995 |
| 19:8811337:A:G | F385L | 0.995 |
| 19:8811671:G:C | F273L | 0.995 |
| 19:8811671:G:T | F273L | 0.995 |
| 19:8811673:A:G | F273L | 0.995 |
| 19:8811755:G:C | F245L | 0.995 |
| 19:8811755:G:T | F245L | 0.995 |
| 19:8811757:A:G | F245L | 0.995 |
| 19:8811923:G:C | F189L | 0.995 |
| 19:8811923:G:T | F189L | 0.995 |
| 19:8811925:A:G | F189L | 0.995 |
| 19:8811419:A:C | F357L | 0.994 |
| 19:8811419:A:T | F357L | 0.994 |
| 19:8811421:A:G | F357L | 0.994 |
| 19:8811560:G:C | H310Q | 0.992 |
| 19:8811560:G:T | H310Q | 0.992 |
| 19:8811812:A:C | H226Q | 0.992 |
| 19:8811812:A:T | H226Q | 0.992 |
| 19:8811570:A:G | L307P | 0.991 |
| 19:8811906:A:G | L195P | 0.991 |
dbSNP variants (sampled 300 via entrez): RS1000158420 (19:8835918 C>A,T), RS1000201811 (19:8838878 A>G), RS1000262306 (19:8821049 G>A,C,T), RS1000263113 (19:8823228 C>T), RS1000326254 (19:8828063 T>A,C), RS1000459045 (19:8833545 GTC>G), RS1000577804 (19:8836523 G>A), RS1000726641 (19:8830994 T>C), RS1000796399 (19:8825696 A>T), RS1000831242 (19:8833342 A>G,T), RS1000894868 (19:8815576 T>C,G), RS1000906547 (19:8836711 C>T), RS1000977232 (19:8819734 T>C), RS1001070718 (19:8806079 T>C), RS1001279527 (19:8824561 A>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
20 total (human), top 20 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Cyclosporine | increases expression | 4 |
| GSK-J4 | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | decreases methylation | 1 |
| arsenite | affects binding, decreases reaction | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | increases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| cupric oxide | increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide | affects cotreatment, increases expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Temozolomide | increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Plant Extracts | affects cotreatment, increases expression | 1 |
| Silicon Dioxide | increases expression | 1 |
| Smoke | decreases expression | 1 |
| Tetrachlorodibenzodioxin | increases expression, affects cotreatment | 1 |
| Particulate Matter | increases abundance, increases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_HD28 | HEK293 eGFP-ZNF558 | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.